BIOMAT Database Logo BIOMAT Database Logo

Cancer risk in men exposed in utero to diethylstilbestrol. 2001

W C Strohsnitter, and K L Noller, and R N Hoover, and S J Robboy, and J R Palmer, and L Titus-Ernstoff, and R H Kaufman, and E Adam, and A L Herbst, and E E Hatch
Department of Obstetrics and Gynecology, Tufts University School of Medicine, Boston, MA, USA. wstrohsnitter@lifespan.org

BACKGROUND An association between prenatal diethylstilbestrol (DES) exposure and cancer in men, especially testicular cancer, has been suspected, but findings from case-control studies have been inconsistent. This study was conducted to investigate the association between prenatal DES exposure and cancer risk in men via prospective follow-up. METHODS A total of 3613 men whose prenatal DES exposure status was known were followed from 1978 through 1994. The overall and site-specific cancer incidence rates among the DES-exposed men were compared with those of the unexposed men in the study and with population-based rates. The relative rate (RR) was used to assess the strength of the association between prenatal DES exposure and cancer development. All statistical tests were two-sided. RESULTS Overall cancer rates among DES-exposed men were similar to those among unexposed men (RR = 1.07; 95% confidence interval [CI] = 0.58 to 1.96) and to national rates (RR = 0.99; 95% CI = 0.65 to 1.44). Testicular cancer may be elevated among DES-exposed men, since the RRs for testicular cancer were 3.05 (95% CI = 0.65 to 22.0) times those of unexposed men in the study and 2.04 (95% CI = 0.82 to 4.20) times those of males in the population-based rates. The higher rate of testicular cancer in the DES-exposed men is, however, also compatible with a chance observation. CONCLUSIONS To date, men exposed to DES in utero do not appear to have an increased risk of most cancers. It remains uncertain, however, whether prenatal DES exposure is associated with testicular cancer.

UI MeSH Term Description Entries
D008297 Male Males
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011297 Prenatal Exposure Delayed Effects The consequences of exposing the FETUS in utero to certain factors, such as NUTRITION PHYSIOLOGICAL PHENOMENA; PHYSIOLOGICAL STRESS; DRUGS; RADIATION; and other physical or chemical factors. These consequences are observed later in the offspring after BIRTH. Delayed Effects, Prenatal Exposure,Late Effects, Prenatal Exposure
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D004054 Diethylstilbestrol A synthetic nonsteroidal estrogen used in the treatment of menopausal and postmenopausal disorders. It was also used formerly as a growth promoter in animals. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), diethylstilbestrol has been listed as a known carcinogen. (Merck, 11th ed) Stilbestrol,Agostilben,Apstil,Diethylstilbestrol, (Z)-Isomer,Diethylstilbestrol, Disodium Salt,Distilbène,Stilbene Estrogen,Tampovagan,Estrogen, Stilbene
D004968 Estrogens, Non-Steroidal Non-steroidal compounds with estrogenic activity. Estrogens, Nonsteroidal,Estrogens, Non Steroidal,Non-Steroidal Estrogens,Nonsteroidal Estrogens
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

W C Strohsnitter, and K L Noller, and R N Hoover, and S J Robboy, and J R Palmer, and L Titus-Ernstoff, and R H Kaufman, and E Adam, and A L Herbst, and E E Hatch
Cancer Risk in Women Exposed to Diethylstilbestrol in Utero.
January 2015, Therapie,
W C Strohsnitter, and K L Noller, and R N Hoover, and S J Robboy, and J R Palmer, and L Titus-Ernstoff, and R H Kaufman, and E Adam, and A L Herbst, and E E Hatch
Cancer risk in women exposed to diethylstilbestrol in utero.
August 1998, JAMA,
W C Strohsnitter, and K L Noller, and R N Hoover, and S J Robboy, and J R Palmer, and L Titus-Ernstoff, and R H Kaufman, and E Adam, and A L Herbst, and E E Hatch
Preeclampsia risk in women exposed in utero to diethylstilbestrol.
July 2007, Obstetrics and gynecology,
W C Strohsnitter, and K L Noller, and R N Hoover, and S J Robboy, and J R Palmer, and L Titus-Ernstoff, and R H Kaufman, and E Adam, and A L Herbst, and E E Hatch
Males exposed in utero to diethylstilbestrol.
December 1984, JAMA,
W C Strohsnitter, and K L Noller, and R N Hoover, and S J Robboy, and J R Palmer, and L Titus-Ernstoff, and R H Kaufman, and E Adam, and A L Herbst, and E E Hatch
Birth defects in children of men exposed in utero to diethylstilbestrol (DES).
October 2018, Therapie,
W C Strohsnitter, and K L Noller, and R N Hoover, and S J Robboy, and J R Palmer, and L Titus-Ernstoff, and R H Kaufman, and E Adam, and A L Herbst, and E E Hatch
Breast cancer screening in women exposed in utero to diethylstilbestrol.
April 2009, Journal of women's health (2002),
W C Strohsnitter, and K L Noller, and R N Hoover, and S J Robboy, and J R Palmer, and L Titus-Ernstoff, and R H Kaufman, and E Adam, and A L Herbst, and E E Hatch
Letter to the editor concerning the cancer risk in women exposed to diethylstilbestrol in utero.
September 2017, Therapie,
W C Strohsnitter, and K L Noller, and R N Hoover, and S J Robboy, and J R Palmer, and L Titus-Ernstoff, and R H Kaufman, and E Adam, and A L Herbst, and E E Hatch
Prevalence of gynecologic cancer in women exposed to diethylstilbestrol in utero.
June 2000, The New England journal of medicine,
W C Strohsnitter, and K L Noller, and R N Hoover, and S J Robboy, and J R Palmer, and L Titus-Ernstoff, and R H Kaufman, and E Adam, and A L Herbst, and E E Hatch
Risk of breast cancer in women exposed to diethylstilbestrol in utero: prelimiinary results (United States).
October 2002, Cancer causes & control : CCC,
W C Strohsnitter, and K L Noller, and R N Hoover, and S J Robboy, and J R Palmer, and L Titus-Ernstoff, and R H Kaufman, and E Adam, and A L Herbst, and E E Hatch
Infertility in women exposed to diethylstilbestrol in utero.
December 1983, The Journal of reproductive medicine,
Copied contents to your clipboard!